But it is the price to pay when there is highend

Necker, Pasteur, Curie, Salpetriere, Quinze-Vingts, Gustave-Roussy. All these top sites medicine are well known in the Ile-de-France. How to enhance this concentration of medical knowledge unique in France How to create businesses and jobs in high added value in this world-renowned compost By facilitating exchanges between public and private actors and creating infrastructure conducive to diversity and innovation. Development plan in the Paris region of Christian Blanc to be presented tomorrow, among other things provides the creation of a valley of biomedical research, extending 20 kilometres between major hospitals of the left bank of the capital and the Genopole of Evry.

Objective: to make the Grand Paris a place where it will be good to discover, heal and produce therapies of the future. A sort of El Dorado able to attract and motivate the best researchers in the world. At this level, competitors are rare and out of the borders of the hexagon. London, the undisputed European leader of research with its faculties of Oxford and Cambridge. Boston led by his MIT, his Harvard Medical School and its industrial pharmacy. San Diego, California, rich of its prestigious centres such as the Scripps and the Salk Institute. Not to mention Singapore, which continued unabated its Biopolis Biotech Park project to the markets of China. "Our models are these large scientific centres that combine hospital sites, clinicians and the entrepreneurs," sums up Gilbert Lenoir leading Cancer Villejuif campus, one of the elements of this plan of scientific-industrial development in the Paris region, with the Saclay plateau.

Five years minimum

A long list of obstacles stand before these bodies inevitably multicéphales. Starting with the incredible maze of territorial and administrative structures which transforms into gymkhana any envy of partnership between complementary actors. A unit of academic research often depends on three or four "owners" rarely agree first time to common stock. In Paris intramuros, the experience of the Institute of vision (installed in the enclosure of the Quinze-Vingts hospital) and Institute of the brain and spinal cord (under construction in the Pitié-Salpêtrière hospital) show that it takes a minimum of five years to carry out an idea, when all the actors concerned are in agreement. If, Furthermore, it must be create a ZAC straddles several municipalities, it is taking his evil grin and plan B.

To make the nine in the medical sector, must be often obtained a dozen signatures. In addition to the communal, departmental and regional authorities, concerned hospital, the local University, public research institutions such as CNRS or Inserm, the line ministries (research, health) and the AP - HP. Then financial as the Caisse des Dépôts and the local authorities such as the pole of competitiveness or the Chamber of commerce concerned. Not to mention the city of Paris who is more interested in what is going "beyond the device". Finally, it must find a contractor agrees to carry the project. "The level of Secretary of State of Christian white is the right level of intervention to solve these problems," notes Gilbert Lenoir.

Business incubator

Cancer campus launched in 2005 by the Gustave-Roussy Institute will not escape the unwritten rule of "five years between the idea and the release of land of the first structures". 14 Sponsors negotiated firm for three years before arriving at an agreement which will be announced at the beginning of may for a first stone laid in June. "The delivery of the first buildings is planned for 2011," said Gilbert Lenoir. The pole includes a nursery and hotel of innovative companies in the sector of the living, CNRS and Inserm, hotel residence laboratories and all services support. It is also planned to build a vital pet store to attract researchers and industrialists of the discipline and mutualisées technical platforms. It is finally the agglomeration community of Val de Bièvre which will take the legal and financial site responsibility. Alone, the construction of the business incubator represents an investment of EUR 18 million.

The business plan prepared by the firm of Ernst & Young table on three or four companies per year (from commissioning). The number of jobs created should be of the order of 1,600. A total that will be modest to investments made by the different actors. But it is the price to pay when there is high-end. This site, dedicated to oncology, will be in competition with neighbouring biotech that have flourished in recent years. The incubators of Paris Biotech health Pasteur Biotop and Incuballiance, nurseries and "Paris health Cochin" the Genopole Evry to Paris Biopark, Biocitech and the Saclay Scientipôle scientific parks. He was not sure that all arrive to break through. The example of distant D'evry Genopole, always looking for a centre for pharmaceutical research at the international level after ten years of existence, shows that the road is long to compete with Boston, San Diego or Singapore.